Exact Mass: 247.1064

Exact Mass Matches: 247.1064

Found 41 metabolites which its exact mass value is equals to given mass value 247.1064, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Linamarin

2-Methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanenitrile

C10H17NO6 (247.1056)


Linamarin is a beta-D-glucoside. It is functionally related to a 2-hydroxy-2-methylpropanenitrile. Linamarin is a natural product found in Osteospermum ecklonis, Lotus arenarius, and other organisms with data available. Linamarin is found in coffee and coffee products. Linamarin occurs in manioc (Manihot utilissimus), flax (Linum usitatissimum), Phaseolus lunatus (butter bean), Trifolium repens (white clover) and other plants. First isloated in 1830. Occurs in manioc (Manihot utilissimus), flax (Linum usitatissimum), Phaseolus lunatus (butter bean), Trifolium repens (white clover) and other plants. First isol in 1830. Linamarin is found in many foods, some of which are gooseberry, chinese broccoli, cascade huckleberry, and leek. Linamarin is found in coffee and coffee products. Linamarin occurs in manioc (Manihot utilissimus), flax (Linum usitatissimum), Phaseolus lunatus (butter bean), Trifolium repens (white clover) and other plants. First isloated in 1830. Linamarin, a natural compound, possesses anticancer activity[1]. Linamarin, a natural compound, possesses anticancer activity[1].

   
   

Malonylcarnitine

(3R)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate

C10H17NO6 (247.1056)


Malonylcarnitine is a metabolite that accumulates with specific disruption of fatty-acid oxidation caused by impaired entry of long-chain acylcarnitine esters into the mitochondria and failure of the mitochondrial respiratory chain at complex 11 and malonyl-CoA decarboxylase (EC 4.1.1.9) deficiency (OMIM 248360). Malonylcarnitine has also been found to accumulate in some newborns with medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3) deficiency (OMIM 201450). (PMID 11558490, 15303003, 12651823) [HMDB] Malonylcarnitine is a metabolite that accumulates with specific disruption of fatty-acid oxidation caused by the impaired entry of long-chain acylcarnitine esters into the mitochondria and failure of the mitochondrial respiratory chain at complex 11 and malonyl-CoA decarboxylase (EC 4.1.1.9) deficiency (OMIM: 248360). Malonylcarnitine has also been found to accumulate in some newborns with medium-chain acyl-CoA dehydrogenase (EC 1.3.99.3) deficiency (OMIM: 201450). (PMID:11558490, 15303003, 12651823).

   

(+-)-Carbovir

2-amino-9-[4-(hydroxymethyl)cyclopent-2-en-1-yl]-6,9-dihydro-1H-purin-6-one

C11H13N5O2 (247.1069)


   

Debromodispacamide B

Debromodispacamide B

C11H13N5O2 (247.1069)


   

N-(3-imidazol-1-ylpropyl)-3-nitropyridin-2-amine

N-(3-imidazol-1-ylpropyl)-3-nitropyridin-2-amine

C11H13N5O2 (247.1069)


   

1-isothiocyanato-9-(methylsulfinyl)nonane

1-isothiocyanato-9-(methylsulfinyl)nonane

C11H21NOS2 (247.1064)


   

(-)-debromodihydrohymenialdisine

(-)-debromodihydrohymenialdisine

C11H13N5O2 (247.1069)


   
   

1-Isothiocyanato-9-(methylsulfinyl)-nonane

1-Isothiocyanato-9-(methylsulfinyl)-nonane

C11H21NOS2 (247.1064)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Linamarin

2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]propanenitrile

C10H17NO6 (247.1056)


Linamarin, a natural compound, possesses anticancer activity[1]. Linamarin, a natural compound, possesses anticancer activity[1].

   

Malonylcarnitine

(3S)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate

C10H17NO6 (247.1056)


   

CAR 3:1;O2

3-[(carboxyacetyl)oxy]-4-(trimethylammonio)butanoate;malonylcarnitine

C10H17NO6 (247.1056)


   

Carbovir

(+-)-Carbovir

C11H13N5O2 (247.1069)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Boc-D-Asp-OMe

Boc-D-Asp-OMe

C10H17NO6 (247.1056)


   
   

4-amino-4-(2-carboxyethyl)heptanedioic acid

4-amino-4-(2-carboxyethyl)heptanedioic acid

C10H17NO6 (247.1056)


   

5-Nitro-3-(piperazin-1-yl)-1H-indazole

5-Nitro-3-(piperazin-1-yl)-1H-indazole

C11H13N5O2 (247.1069)


   

diethyl 2-(1-nitroethyl)butanedioate

diethyl 2-(1-nitroethyl)butanedioate

C10H17NO6 (247.1056)


   

DIMETHYL (BOC-AMINO)MALONATE

DIMETHYL (BOC-AMINO)MALONATE

C10H17NO6 (247.1056)


   

N-tert-Butoxycarbonyl-L-aspartic acid 1-methyl ester

N-tert-Butoxycarbonyl-L-aspartic acid 1-methyl ester

C10H17NO6 (247.1056)


   

D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-METHYL ESTER

D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-METHYL ESTER

C10H17NO6 (247.1056)


   

2-Bromo-4-methylbenzoic acid

2-Bromo-4-methylbenzoic acid

C10H17NO6 (247.1056)


   
   

2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid

2-((tert-Butoxycarbonyl)amino)-3-ethoxy-3-oxopropanoic acid

C10H17NO6 (247.1056)


   

2-((TERT-BUTOXYCARBONYL)AMINO)-4-METHOXY-4-OXOBUTANOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-4-METHOXY-4-OXOBUTANOIC ACID

C10H17NO6 (247.1056)


   

5-[2-(Cbz-amino)ethyl]-1H-tetrazole

5-[2-(Cbz-amino)ethyl]-1H-tetrazole

C11H13N5O2 (247.1069)


   

2-Acetamido-2-(hydroxymethyl)propanedioic acid diethyl ester

2-Acetamido-2-(hydroxymethyl)propanedioic acid diethyl ester

C10H17NO6 (247.1056)


   

6-(2-Phenoxyethoxy)-1,3,5-Triazine-2,4-Diamine

6-(2-Phenoxyethoxy)-1,3,5-Triazine-2,4-Diamine

C11H13N5O2 (247.1069)


   

O-Malonyl-L-carnitine

O-Malonyl-L-carnitine

C10H17NO6 (247.1056)


An O-acyl-L-carnitine in which the acyl group is specified as malonyl.

   

O-malonylcarnitine

O-malonylcarnitine

C10H17NO6 (247.1056)


An O-acylcarnitine having malonyl as the acyl substituent.

   

(3S)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate

(3S)-3-[(2-carboxyacetyl)oxy]-4-(trimethylazaniumyl)butanoate

C10H17NO6 (247.1056)


   
   

1-isothiocyanato-9-methanesulfinylnonane

1-isothiocyanato-9-methanesulfinylnonane

C11H21NOS2 (247.1064)


   

(5r)-5-[(4s)-8-hydroxy-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-4-yl]-2-imino-1,5-dihydroimidazol-4-ol

(5r)-5-[(4s)-8-hydroxy-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-4-yl]-2-imino-1,5-dihydroimidazol-4-ol

C11H13N5O2 (247.1069)


   

1-isothiocyanato-9-[(s)-methanesulfinyl]nonane

1-isothiocyanato-9-[(s)-methanesulfinyl]nonane

C11H21NOS2 (247.1064)


   

(2r)-2-{[(1s)-1-carboxy-2-methylpropyl]amino}pentanedioic acid

(2r)-2-{[(1s)-1-carboxy-2-methylpropyl]amino}pentanedioic acid

C10H17NO6 (247.1056)


   

n-[3-(5-hydroxy-2-imino-3h-imidazol-4-ylidene)propyl]-1h-pyrrole-2-carboxamide

n-[3-(5-hydroxy-2-imino-3h-imidazol-4-ylidene)propyl]-1h-pyrrole-2-carboxamide

C11H13N5O2 (247.1069)


   

2-[(1-carboxy-2-methylpropyl)amino]pentanedioic acid

2-[(1-carboxy-2-methylpropyl)amino]pentanedioic acid

C10H17NO6 (247.1056)


   

(5s)-5-[(4s)-8-hydroxy-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-4-yl]-2-imino-1,5-dihydroimidazol-4-ol

(5s)-5-[(4s)-8-hydroxy-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-4-yl]-2-imino-1,5-dihydroimidazol-4-ol

C11H13N5O2 (247.1069)


   

n-{3-[(4z)-5-hydroxy-2-imino-3h-imidazol-4-ylidene]propyl}-1h-pyrrole-2-carboxamide

n-{3-[(4z)-5-hydroxy-2-imino-3h-imidazol-4-ylidene]propyl}-1h-pyrrole-2-carboxamide

C11H13N5O2 (247.1069)